Back
SAB Biotherapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
SABS
SAB Biotherapeutics
Last Price:
$2.81
Seasonality Move:
-20.91%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SABS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SAB Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.64 | Buy |
20-day SMA: | 2.12 | Buy |
50-day SMA: | 1.94 | Buy |
200-day SMA: | 2.42 | Buy |
8-day EMA: | 2.33 | Buy |
20-day EMA: | 1.46 | Buy |
50-day EMA: | 0.72 | Buy |
200-day EMA: | 0.2 | Buy |
SAB Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.75 | Buy |
Relative Strength Index (14 RSI): | 75.34 | Buy |
Chaikin Money Flow: | 16605 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.64 - 2.46) | Buy |
Bollinger Bands (100): | (1.39 - 2.07) | Buy |
SAB Biotherapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SAB Biotherapeutics Stock
Is SAB Biotherapeutics Stock a Buy?
-
SAB Biotherapeutics share price is 2.84 while SABS 8-day simple moving average is 2.64, which is a Buy signal.
-
The stock price of SABS is 2.84 while SAB Biotherapeutics 20-day SMA is 2.12, which makes it a Buy.
-
SAB Biotherapeutics 50-day simple moving average is 1.94 while SABS share price is 2.84, making it a Buy technically.
-
SABS stock price is 2.84 and SAB Biotherapeutics 200-day simple moving average is 2.42, creating a Buy signal.
SABS Technical Analysis vs Fundamental Analysis
Sell
46
SAB Biotherapeutics (SABS)
is a Sell
Is SAB Biotherapeutics a Buy or a Sell?
-
SAB Biotherapeutics stock is rated a SellThe current SAB Biotherapeutics [SABS] share price is $2.84. The Score for SABS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
SAB Biotherapeutics Stock Info
Market Cap:
26.4M
Price in USD:
2.84
Share Volume:
29K
SAB Biotherapeutics 52-Week Range
52-Week High:
5.01
52-Week Low:
1.00
Sell
46
SAB Biotherapeutics (SABS)
is a Sell
SAB Biotherapeutics Share Price Forecast
-
What is the SAB Biotherapeutics stock price today?The SAB Biotherapeutics stock price is 2.84 USD today.
-
Will SABS stock go up or go down?SAB Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SAB Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SAB Biotherapeutics is overvalued.
Is SAB Biotherapeutics Stock a Buy?
-
SAB Biotherapeutics share price is 2.84 while SABS 8-day exponential moving average is 2.33, which is a Buy signal.
-
The stock price of SABS is 2.84 while SAB Biotherapeutics 20-day EMA is 1.46, which makes it a Buy.
-
SAB Biotherapeutics 50-day exponential moving average is 0.72 while SABS share price is 2.84, making it a Buy technically.
-
SABS stock price is 2.84 and SAB Biotherapeutics 200-day simple moving average is 0.20, creating a Buy signal.
Fundamental Analysis of SAB Biotherapeutics
Is SAB Biotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.37 per share, and a decrease next year of $0.65 per share.
Technical Analysis of SAB Biotherapeutics
Should I short SAB Biotherapeutics stock?
-
SABS Moving Average Covergence Divergence (MACD) indicator is 0.75, suggesting SAB Biotherapeutics is a Buy
-
SAB Biotherapeutics Relative Strength Index (RSI) is 75.34, which suggest SAB Biotherapeutics is overbought
-
The Bollinger Bands (25) for SAB Biotherapeutics is (1.64 - 2.46), which suggest SAB Biotherapeutics is a Buy
-
The Bollinger Bands (100) for SAB Biotherapeutics is (1.39 - 2.07), which suggest SAB Biotherapeutics is a Buy
* SAB Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.